wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38625550-F427E65E-6D44-4902-A63D-1012A744D6F3
Q38625550-F427E65E-6D44-4902-A63D-1012A744D6F3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38625550-F427E65E-6D44-4902-A63D-1012A744D6F3
Targeted therapies for treatment of non-small cell lung cancer--Recent advances and future perspectives.
P2860
Q38625550-F427E65E-6D44-4902-A63D-1012A744D6F3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38625550-F427E65E-6D44-4902-A63D-1012A744D6F3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
36074642129d5e695cc2047a85edb74a7c4f8032
P2860
A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinib.